Log In
BCIQ
Print this Print this
 

Depacon, valproate

  Manage Alerts
Collapse Summary General Information
Company Abbott Laboratories
DescriptionValproate has multiple mechanisms of action including HDAC inhibition
Molecular Target Histone deacetylase (HDAC)
Mechanism of ActionHistone deacetylase (HDAC) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationBipolar disorder
Indication DetailsTreat acute manic or mixed episodes associated with bipolar disorder.
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today